Why Is Hims & Hers Stock Soaring After FDA’s Announcment?

All NewsApril 16, 2026

Hims & Hers stock rises as FDA plans to ease peptide therapy rules, opening new revenue opportunities and shifting regulatory outlook.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent